PURE Bioscience Reports Fiscal Second Quarter 2026 Financial Results
Businesswire·2026-03-16 20:05
PURE Bioscience Reports Fiscal Second Quarter 2026 Financial Results Mar 16, 2026 4:05 PM Eastern Daylight Time PURE Bioscience Reports Fiscal Second Quarter 2026 Financial Results Share EL CAJON, Calif.--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE,†the "Company†or "we†), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal second quarter ended January 31, 2026. We received the long-awaited USDA Biobased Product Ce ...